In addition, we conducted nuclear plasma separation experiments and found that YAP1 and TET1 proteins in the nuclei of sorafenib- resistant HCC cells were significantly higher than those in the cytoplasm. This evidence concerns the gene TET1 and hepatocellular carcinoma.